For Some African-Americans, Genetic Testing Reopens Past Wounds
By Amy Dockser Marcus,
The Wall Street Journal
| 07. 14. 2018
Late last year, Justina Crawford decided to swab the inside of her mouth for a saliva sample to do a DNA test.
Ms. Crawford, a 30-year-old working in Boston who is African-American, had never done a DNA test before because she worried about who would have access to her genetic information. But her growing curiosity about her family history led her to set her reservations aside. “I want to know my roots,” she said, and purchased a kit from African Ancestry Inc., a DNA testing company.
Scientists and private genetic testing companies are making a push to enroll more African-Americans in genetic research and databases. As the popularity and wider availability of genetic testing grows, so have calls from the scientific community about the need for genetic diversity in future research. In the past, genomic research was predominantly skewed to people of European ancestry. As a result, African-Americans—as well as people of different demographic backgrounds—weren’t well represented in some important health research.
But before they sign up, many African-Americans have to overcome concern about potential misuse of DNA results and...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
